5ESV image
Entry Detail
PDB ID:
5ESV
Keywords:
Title:
Crystal Structure of Broadly Neutralizing Antibody CH03, Isolated from Donor CH0219, in Complex with Scaffolded Trimeric HIV-1 Env V1V2 Domain from the Clade C Superinfecting Strain of Donor CAP256.
Biological Source:
PDB Version:
Deposition Date:
2015-11-17
Release Date:
2015-12-16
Method Details:
Experimental Method:
Resolution:
3.11 Å
R-Value Free:
0.25
R-Value Work:
0.20
R-Value Observed:
0.21
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:CH03 Heavy Chain
Chain IDs:A, C, H
Chain Length:244
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:CH03 Light Chain
Chain IDs:B, D, I (auth: L)
Chain Length:215
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase,Envelope glycoprotein gp160
Chain IDs:E, F, G
Chain Length:211
Number of Molecules:3
Biological Source:Haemophilus influenzae, Human immunodeficiency virus 1, Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)
Primary Citation

Abstact

Broadly neutralizing antibodies (bNAbs) against HIV-1 Env V1V2 arise in multiple donors. However, atomic-level interactions had previously been determined only with antibodies from a single donor, thus making commonalities in recognition uncertain. Here we report the cocrystal structure of V1V2 with antibody CH03 from a second donor and model Env interactions of antibody CAP256-VRC26 from a third donor. These V1V2-directed bNAbs used strand-strand interactions between a protruding antibody loop and a V1V2 strand but differed in their N-glycan recognition. Ontogeny analysis indicated that protruding loops develop early, and glycan interactions mature over time. Altogether, the multidonor information suggested that V1V2-directed bNAbs form an 'extended class', for which we engineered ontogeny-specific antigens: Env trimers with chimeric V1V2s that interacted with inferred ancestor and intermediate antibodies. The ontogeny-based design of vaccine antigens described here may provide a general means for eliciting antibodies of a desired class.

Legend

Protein

Chemical

Disease

Primary Citation of related structures